Novartis Ag (NVS) Gross Profit (2009 - 2026)
Novartis Ag (NVS) posted Gross Profit of $11.2 billion for Q2 2026, down 2.37% sequentially from $11.5 billion in Q2 2025, and down 2.37% YoY from $11.5 billion in Q2 2025.
Novartis Ag (NVS) Gross Profit (2009 - 2026) Analysis & Trends
Novartis Ag has reported Gross Profit for 18 years, with the latest figure at $11.2 billion in Q2 2026.
- Quarterly Gross Profit fell 2.37% year-over-year to $11.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $51.2 billion (down 9.25% YoY) and the FY2025 annual result came in at $43.0 billion, up 10.49% from the prior year.
- Gross Profit retreated to $11.2 billion in Q2 2026 per NVS's latest filing, from $11.5 billion in the prior quarter.
- Over five years, Gross Profit peaked at $34000.0 billion in Q1 2022 and troughed at $1.0 million in Q3 2022.
- A 5-year average of $3554.9 billion and a median of $11.5 billion in 2025 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 130557.14% in 2022, down 95.24% in 2022.
- Over 5 years, Gross Profit stood at $18.3 billion in 2022, then decreased by 10.02% to $16.5 billion in 2023, then gained by 13.76% to $18.7 billion in 2024, then tumbled by 38.5% to $11.5 billion in 2025, then fell by 2.37% to $11.2 billion in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $11.2 billion, $11.5 billion, and $18.7 billion for Q2 2026, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24 Bn |
| Jun 30, 2026 | 11.24 Bn |
| Jun 30, 2025 | 11.51 Bn |
| Jun 30, 2025 | 11.51 Bn |
| Dec 31, 2024 | 18.72 Bn |
| Dec 31, 2024 | 18.72 Bn |
| Jun 30, 2024 | 9.70 Bn |
| Jun 30, 2024 | 9.70 Bn |
| Dec 31, 2023 | 16.46 Bn |
| Dec 31, 2023 | 16.46 Bn |
| Jun 30, 2023 | 8.40 Bn |
| Jun 30, 2023 | 8.40 Bn |
| Mar 31, 2023 | 5,000.00 Bn |
| Mar 31, 2023 | 5,000.00 Bn |
| Dec 31, 2022 | 18.29 Bn |
| Dec 31, 2022 | 18.29 Bn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 9.33 Bn |
| Jun 30, 2022 | 9.33 Bn |